Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Rex MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rex MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 157 · Grade C

Rex MD

Visit Rex MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Rex MD a bad call — it's best for readers considering branded oral semaglutide who can confirm the complete agreement and manufacturer-pharmacy fulfillment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
77
Transparency
90
48
Access Breadth
93
96
Clinical Oversight
92
84
Track Record
88
78
CoreAge RxBrief Score 94 · 71Rex MD

Price, coverage & the tracker

CoreAge RxRex MD
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the Wegovy pill agreement

Advertised from $349/month for the Wegovy pill and provider care; injectable Wegovy needs its own quote.

Full price details

Brand Wegovy pill offered; complete selected agreement and injectable quote unknown; advertised pill medication and care from $349/month; earlier listing: From $199/mo (brand-name)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current tirzepatide quote unknown

Zepbound vial advertised; dose, supply and complete care cost unconfirmed. The Wegovy pill offer is separate.

Full price details

Brand Zepbound vial advertised; current dose-specific complete medication and care quote unknown; earlier listing: From $349/mo (brand Zepbound)

CoverageUS only; restrictions by state, confirmed at intakeSelected treatment availability depends on patient location, clinician licensing and pharmacy eligibility; confirm your state
Brand-name accessNot confirmedWegovy and a homepage Zepbound vial option are advertised; the pill price does not apply to every brand, route or dose.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Rex MD: Current weight-management page advertises Wegovy pill from $349/month with provider care. Do not apply that price to injectable Wegovy or Zepbound.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.